Safety and Immunogenicity Of A Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) Administered In Healthy Meningococcal Vaccine-Naive Children (2-9 Years)

被引：0
|
作者：
Simon, Michael
Zomcik, Anne
Brandon, Donald
Christensen, Shane
Baccarini, Carmen
Jordanov, Emilia
Dhingra, Mandeep S.
机构：
来源：
PEDIATRICS | 2021年 / 147卷 / 03期
关键词：
D O I：
10.1542/peds.147.3MA3.309
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Immunogenicity and safety of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT) vs. a licensed quadrivalent meningococcal tetanus toxoid-conjugate vaccine in meningococcal vaccine-naive and meningococcal C conjugate vaccine-primed toddlers: a phase III randomised study
    van der Vliet, D.
    Vesikari, T.
    Sandner, B.
    Martinon-Torres, F.
    Muzsay, G.
    Forsten, A.
    Adelt, T.
    Diaz Gonzalez, C.
    Simko, R.
    B'Chir, S.
    Neveu, D.
    Jordanov, E.
    Dhingra, M. S.
    EPIDEMIOLOGY AND INFECTION, 2021, 149
  • [2] Safety and Immunogenicity of a Quadrivalent Meningococcal Conjugate Vaccine in Healthy Meningococcal-Naive Children 2-9 Years of Age: A Phase III, Randomized Study
    Baccarini, Carmen I.
    Simon, Michael W.
    Brandon, Donald
    Christensen, Shane
    Jordanov, Emilia
    Dhingra, Mandeep S.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2020, 39 (10) : 955 - 960
  • [3] Comparing the meningococcal serogroup C immune response elicited by a tetanus toxoid conjugate quadrivalent meningococcal vaccine (MenACYW-TT) versus a quadrivalent or monovalent C tetanus toxoid conjugate meningococcal vaccine in healthy meningococcal vaccine-naive toddlers: A randomised, controlled trial
    Knuf, Markus
    Ramet, Mika
    Staerke, Nina Breinholt
    Bertrand-Gerentes, Isabelle
    Thollot, Yael
    B'Chir, Siham
    Arroum, Habiba
    Oster, Philipp
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022, 18 (05)
  • [4] A Phase II, randomized, immunogenicity and safety study of a quadrivalent meningococcal conjugate vaccine, MenACYW-TT, in healthy adolescents in the United States
    Chang, Lee-Jah
    Hedrick, James
    Christensen, Shane
    Pan, Judy
    Jordanov, Emilia
    Dhingra, Mandeep S.
    VACCINE, 2020, 38 (19) : 3560 - 3569
  • [5] Immunogenicity and safety of a quadrivalent meningococcal conjugate vaccine (MenACYW-TT) administered as a booster to adults aged ≥59 years: A phase III randomized study
    Robertson, Corwin A.
    Jacqmein, Jeffry
    Selmani, Alexandre
    Galarza, Katherine
    Oster, Philipp
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2023, 19 (01)
  • [6] Five-Year Immune Persistence of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) and Immunogenicity and Safety of a Booster Dose in Children
    Martinon-Torres, Federico
    Simko, Robert
    Ebert, Rolf
    Ramet, Mika
    Zocchetti, Celine
    Syrkina, Olga
    Bchir, Siham
    Bertrand-Gerentes, Isabelle
    INFECTIOUS DISEASES AND THERAPY, 2025,
  • [7] Immunogenicity and safety of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT): A review of the evidence and expert opinion
    Ricci, Silvia
    Azzari, Chiara
    Amodio, Emanuele
    Castiglia, Paolo
    EXPERT REVIEW OF VACCINES, 2023, 22 (01) : 447 - 456
  • [8] Immunogenicity and safety of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT) in healthy toddlers: a Phase II randomized study
    Vesikari, Timo
    Borrow, Ray
    Forsten, Aino
    Findlow, Helen
    Dhingra, Mandeep S.
    Jordanov, Emilia
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2020, 16 (06) : 1306 - 1312
  • [9] Immune Persistence, Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) Administered as a Booster Dose in Adolescents and Adults Vaccinated Against Meningococcal Disease 3-6 Years Earlier
    Dhingra, Mandeep Singh S.
    Peterson, James
    Deseda, Carmen
    Julien, Katie
    Zambrano, Betzana
    Anez, German
    Shi, Jiayuan
    Pan, Judy
    Arroum, Habiba
    Varghese, Kucku
    Jordanov, Emilia
    PEDIATRICS, 2022, 149 (01)
  • [10] Immunogenicity and safety of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT) in adults 56 years of age and older: a Phase II randomized study
    Kirstein, Judith
    Pina, Miriam
    Pan, Judy
    Jordanov, Emilia
    Dhingra, Mandeep S.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2020, 16 (06) : 1299 - 1305
12345